BIOTECHNOLOGY ADVANCES Research Reviews
Total Page：16
File Type：pdf, Size：1020Kb
BIOTECHNOLOGY ADVANCES Research Reviews AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.3 ISSN: 0734-9750 DESCRIPTION . Biotechnology Advances is a review journal which considers all aspects of the multidisciplinary field. The scope includes biotechnology principles and applications in industry, agriculture, medicine, environmental concerns and regulatory issues. Authoritative articles on current developments and future trends in biotechnology are empathized. Submissions of appropriate manuscripts are invited. A wide audience of scientists, engineers and others is addressed: students, instructors, researchers, practitioners, managers, governments and related stakeholders. Special issues are published on selections of presentations at recent relevant conferences as arranged with the organizations. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center AUDIENCE . Biotechnologists, Technical Biochemists, Microbiologists, Molecular Biologists, Environmental Scientists, Genetic Engineers, Biochemical and Environmental Engineers involved in pharmaceuticals, foods and beverages, fuels, chemicals, waste treatment, agriculture, mining and medicine. IMPACT FACTOR . 2020: 14.227 © Clarivate Analytics Journal Citation Reports 2021 AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/biotechadv 1 ABSTRACTING AND INDEXING . Research Alert BIOSIS Citation Index Elsevier BIOBASE Cambridge Scientific Abstracts Current Biotechnology Abstracts Chemical Abstracts Current Contents - Agriculture, Biology & Environmental Sciences Current Contents Current Contents EMBiology Scopus INSPEC EDITORIAL BOARD . Editor in Chief A. Bayer, Weizmann Institute of Science Department of Biomolecular Sciences, Rehovot, Israel Editors H. Alper, The University of Texas at Austin, Austin, Texas, United States of America F. Bai, Shanghai Jiao Tong University - MinHang Campus, Shanghai, China N. Borth, University of Natural Resources and Life Sciences Vienna, Wien, Austria C.P. Chou, University of Waterloo, Waterloo, Ontario, Canada M. Koffas, Rensselaer Polytechnic Institute Department of Chemical Engineering, Troy, New York, United States of America Founding Editor M. Moo-Young, University of Waterloo, Waterloo, Ontario, Canada Book Review Editor Y. Chisti, Massey University, Palmerston North, New Zealand Editorial Board S.N. Agathos, Catholic University of Louvain, Louvain-la-Neuve, Belgium H.N. Chang, Korea Advanced Institute of Science and Technology, Daejeon, South Korea P.M. Doran, University of New South Wales, Sydney, New South Wales, Australia B.R. Glick, University of Waterloo, Waterloo, Ontario, Canada G. Goma, Toulouse School of Engineering, Toulouse, France V.K. Gupta, Scotland's Rural College, Edinburgh, United Kingdom W.-S. Hu, University of Minnesota Twin Cities, Minneapolis, Minnesota, United States of America J. Kas, University of Chemistry and Technology Prague Department of Biochemistry and Microbiology, Praha, Czechia J.H.T. Luong, National Research Council Canada, Ottawa, Ontario, Canada E.J. Olguin, Institute of Ecology, Xalapa, Mexico S.S. Ozturk, GlaxoSmithKline USA, King of Prussia, Pennsylvania, United States of America K. S. M. S. Raghavarao, CSIR - Central Food Technological Research Institute, Mysore, India L.S. Tran, RIKEN Center for Sustainable Resource Science, Yokohama, Japan T. Yoshida, Osaka University International Center for Biotechnology, Suita, Japan D. Zhang, Shanghai Jiao Tong University - Fahua Campus, Shanghai, China J. Zhang, University of Ottawa, Ottawa, Ontario, Canada X.-Q. Zhao, Shanghai Jiao Tong University - Fahua Campus, Shanghai, China AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/biotechadv 2 GUIDE FOR AUTHORS . INTRODUCTION Biotechnology Advances is a review journal which considers all aspects of the multidisciplinary field. The scope includes biotechnology principles and applications in industry, agriculture, medicine, environmental concerns and regulatory issues. Authoritative articles on current developments and future trends in biotechnology are empathized. Submissions of appropriate manuscripts are invited. A wide audience of scientists, engineers and others is addressed: students, instructors, researchers, practitioners, managers, governments and related stakeholders. Special issues are published on selections of presentations at recent relevant conferences as arranged with the organizations. Special issues are also produced to review areas of biotechnology which are inadequately covered in a focused and/or timely manner in regular issues, as arranged with invited guest editors. Types of paper Review articles, both short and longer extensive ones are considered. The review article should demonstrate insights of the topic with regard to current developments and future trends in biotechnology. The author(s) should give evidence in the literature of appropriate expertise, for example in the publications cited in the proposed manuscript. Contact details for submission Papers should be submitted using the Biotechnology Advances online submission system, https://www.editorialmanager.com/jba For questions, please visit our Support Center BEFORE YOU BEGIN Plagiarism All JBA submissions will be subjected to plagiarism evaluation using the software of iThenticate/ Crosscheck prior to editorial processing. Authors should be experienced enough to differentiate ethical behaviors (e.g. citation and quotation) from unethical ones (e.g. general plagiarism, self-plagiarism, and copy-and-paste). Manuscripts that cannot pass the plagiarism evaluation pre-screening will be automatically rejected without review and the plagiarism evaluation will not be provided to authors. For more information, please go to: https://www.elsevier.com/editors/perk/plagiarism-detection Ethics in publishing Please see our information on Ethics in publishing. Conflict of interest All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within five years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also https://www.elsevier.com/conflictsofinterest. Submission declaration Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright- holder. Preprints Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information). Use of inclusive language Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/biotechadv 3 to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive. Author contributions For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example Authorship All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising